US Stock MarketDetailed Quotes
AMRN Amarin
- 0.778
- -0.027-3.37%
Close Jun 14 16:00 ET
319.70MMarket Cap-5985P/E (TTM)
0.820High0.770Low1.29MVolume0.820Open0.805Pre Close1.02MTurnover0.34%Turnover RatioLossP/E (Static)410.87MShares1.48552wk High0.59P/B298.25MFloat Cap0.62752wk Low--Dividend TTM383.30MShs Float675.000Historical High--Div YieldTTM6.21%Amplitude0.460Historical Low0.787Avg Price1Lot Size
Amarin Stock Forum
Sign in to post a comment
$Amarin(AMRN.US$ Reported Saturday, New REDUCE-IT Analyses By Amarin Show That VASCEPA/VAZKEPA Benefits High-Risk Cardiovascular Disease Patient Subgroups
$Amarin(AMRN.US$ Amarin Received Decision To Grant From European Patent Office For New Patent Covering VAZKEPA That Will Extend VAZKEPA Exclusivity Eight Additional Years Into 2039
$Amarin(AMRN.US$ Amarin Says Initiated Shareholder Approval Process To Execute Share Repurchase Program Of Up To $50M By End Of Q2 2024
1
$Amarin(AMRN.US$ Officer Holt Patrick purchased 14,426 shares of Common Stocks on Jan 22, 2024 at an average price of $1.09 for a total value of $15,724.34.![]()
2
1
$Amarin(AMRN.US$ Amarin Plans To Initiate Share Repurchase Program of Up to $50M
Moomoo 24/7· 1 min ago![]()
Moomoo 24/7· 1 min ago
2
Amarin's low P/S ratio is due to declining revenue and expectations of below-average growth. Lack of investor confidence in future revenue growth may further affect its share price if no improvements are made.
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
The Real WojakOP : Sold $0.81 thanks for the money